BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kabatas S, Civelek E, Savrunlu EC, Kaplan N, Akkoc T, Küçükçakır N, Bozkurt M, Karaöz E. Efficacy and safety of exosomes from Wharton’s Jelly-derived mesenchymal stem cells in traumatic brain injury. World J Crit Care Med 2025; 14(4): 103782 [PMID: 41377533 DOI: 10.5492/wjccm.v14.i4.103782]
URL: https://www.wjgnet.com/2220-3141/full/v14/i4/103782.htm
Number Citing Articles
1
Na Liu, Xue Zhao, Xicai Sun, Yongmei Liu, Jing Xu, Donghua Xu, Wenchang Sun. Mesenchymal stem cells-derived extracellular vesicles as a novel drug delivery carrier: engineering strategies and clinical safety estimationFrontiers in Molecular Biosciences 2026; 13 doi: 10.3389/fmolb.2026.1838554
2
Shen Yang, Siliang Ge, Zhongyang Liu, Junyu Chen, Feifan Chang, Junmin Shen, Fanfeng Wu, Xinyu Sun, Zhongqi Wang, Yi Li, Mingming Zhang, Ruijing Chen, Taojin Feng, Tao Yin, Pincong Fu, Ming Chen, Pengbin Yin, Libo Hao. Exosome-enabled bone defect repair: mechanistic foundations, bioengineered delivery, and artificial intelligence-driven translationJournal of Nanobiotechnology 2026; 24(1) doi: 10.1186/s12951-026-04176-w
3
Meiqi Chen, Chenyang Gu, Yishen Lai, Yuqi Lin, Yifan Xu, Xiaoyin Li, Xuyi Chen. Exosome-Based Diagnostics and Cell-Free Therapeutics for Traumatic Brain Injury: From Mechanisms to BedsideInternational Journal of Nanomedicine 2026;  doi: 10.2147/IJN.S580440
4
Ye Xiong, Yanlu Zhang, Zheng Gang Zhang, Michael Chopp. Mesenchymal stromal/stem cell-derived extracellular vesicles as a cell-free therapeutic strategy for traumatic brain injuryBrain Medicine 2026;  doi: 10.61373/bm026i.0048